When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 15 Mar 2025
Last updated: 21 Aug 2024

Summary

Definition

History and exam

Key diagnostic factors

  • sudden onset and brief duration of symptoms (minutes)
  • patient/witness report of focal neurological deficit

Other diagnostic factors

  • unilateral weakness or paralysis
  • dysphasia
  • ataxia, vertigo, or loss of balance
  • sudden transient loss of vision in one eye (amaurosis fugax)
  • homonymous hemianopia
  • diplopia
  • risk factors

Risk factors

  • atrial fibrillation
  • valvular disease
  • carotid stenosis
  • intracranial stenosis
  • congestive heart failure
  • hypertension
  • hyperlipidaemia
  • diabetes mellitus
  • cigarette smoking
  • alcohol-use disorder
  • advanced age
  • patent foramen ovale (PFO)
  • inactivity
  • obesity
  • hypercoagulability

Diagnostic investigations

1st investigations to order

  • blood glucose
  • full blood count and platelet count
  • prothrombin time, INR, partial thromboplastin time
  • fasting lipid profile
  • serum electrolytes
  • ECG

Treatment algorithm

Contributors

Expert advisers

Matthew Jones, MD, FRCP

Consultant Neurologist

Manchester Centre for Clinical Neurosciences

Northern Care Alliance

Honorary Senior Lecturer

University of Manchester

Manchester

UK

Disclosures

MJ is the chair of the Association of British Neurologists Education Committee (unpaid position). MJ is a faculty member of a MRCP revision course. MJ has received honoraria from Eisai for educational talks.

Rachael Power, MBChB, MRCP

Neurology Registrar

Manchester Centre for Clinical Neurosciences

Manchester

UK

Disclosures

RP has been sponsored by Novartis to attend the International Headache Conference.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:

Jennifer Simpson, MD

Associate Assistant Professor

Department of Neurology

University of Colorado School of Medicine

Denver

CO

Disclosures: JS is a site investigator for the POINT trial.

Ethan Cumbler, MD

Associate Professor

Section of Hospital Medicine

Department of Internal Medicine

Division of Medicine

University of Colorado School of Medicine

Denver

CO

Disclosures: EC declares that he has no competing interests.

Peer reviewers

Kayvan Khadjooi, MD, FRCP, PGCertMedEd

Consultant in Stroke Medicine

Addenbrooke’s Hospital

Associate Lecturer

School of Clinical Medicine

University of Cambridge

Cambridge

UK

Disclosures

KK has received travel grants for conferences/speaker honoraria from Bayer, Boehringer, Daiichi-Sankyo, Pfizer, and Shire.

Use of this content is subject to our disclaimer